- Home
- Toritz Ra 500Mg/50Ml Inj
Toritz Ra 500Mg/50Ml Inj Substitute
Toritz Ra 500Mg/50Ml Inj Substitute
Lupiximab 500mg Injection
by Others
₹240.91per tabletRuximonab 500 mg Injection 50 ml
by Others
₹600.00per tabletRixilta 500 Injection 50 ml
by Others
₹623.95per tabletMaball 500 mg Injection 50 ml
by Others
₹628.34per tabletRitucad 500 mg Injection 50 ml
by Others
₹655.87per tabletRituxem 500 mg Injection 50 ml
by Others
₹655.92per tabletRituxirel RN 500 mg Injection 50 ml
by Others
₹667.28per tabletRituxy 500 Injection 50 ml
by Others
₹713.41per tabletMabtas N 500 mg Injection 50 ml
by Others
₹732.43per tabletRituxipca 500 mg Injection 50 ml
by Others
₹773.24per tabletEmtux 500 mg Injection 50 ml
by Others
₹773.42per tabletMabtas RA 500 Injection 50 ml
by Others
₹813.81per tabletRituxipan 500 mg Injection 50 ml
by Others
₹851.56per tabletEnfiera 500 Injection 1's
by Others
₹32793.40per tabletReditux 500 Injection 1's
by Others
₹33364.20per tablet
Verified Ingredients and Effects
Composition:
RITUXIMAB-500MG
Uses:
<p>Toritz Ra 500Mg/50Ml Inj is used in the treatment of Non-Hodgkin’s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris. The detailed uses of Toritz Ra 500Mg/50Ml Inj are as follows:</p><ul><li><strong>Non-Hodgkin’s Lymphoma (NHL) :</strong> Toritz Ra 500Mg/50Ml Inj is used to treat Non-Hodgkin’s Lymphoma alone or with chemotherapy.</li><li><strong>Chronic Lymphocytic Leukemia (CLL) :</strong> Toritz Ra 500Mg/50Ml Inj is used in the treatment of Chronic Lymphocytic Leukemia (CLL) and B-cell Acute Lymphoblastic Leukemia (B-ALL.</li><li><strong>Rheumatoid Arthritis (RA):</strong> Toritz Ra 500Mg/50Ml Inj is used in the treatment of rheumatoid arthritis.</li><li><strong>Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA):</strong> Toritz Ra 500Mg/50Ml Inj helps to treat Granulomatosis with Polyangiitis and Microscopic Polyangiitis.</li><li><strong>Pemphigus Vulgaris:</strong> Toritz Ra 500Mg/50Ml Inj is used to treat pemphigus vulgaris for moderate to severe cases.</li></ul>
Medicinal Benefits:
Toritz Ra 500Mg/50Ml Inj contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Toritz Ra 500Mg/50Ml Inj works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.
FAQs
Toritz Ra 500Mg/50Ml Inj is used to treat Non-Hodgkin’s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris.
Toritz Ra 500Mg/50Ml Inj contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.
Toritz Ra 500Mg/50Ml Inj may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Toritz Ra 500Mg/50Ml Inj contains the active substance rituximab. This is a type of protein called a monoclonal antibody.
The common side effects of Toritz Ra 500Mg/50Ml Inj are pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. If any of these side effects persist or worsen, please consult your doctor.
